YAP1 and chronic kidney disease: Thus, YAP1-inhibition initiated right after the early injury phase of AKI, can attenuate ongoing polyploidization of TC, which is sufficient to prevent the long-term trade-off of this survival mechanism, i.e., AKI-CKD transition.